Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer
Clinical trial NCT02401971 · UNKNOWN
Trial details
- NCT number
- NCT02401971
- Sponsor
- Wang Jufeng
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2016-08-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.